143 related articles for article (PubMed ID: 18632214)
1. Effect of pretreatment anemia on treatment outcome of concurrent radiochemotherapy in patients with head and neck cancer.
Fortin A; Wang CS; Vigneault E
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):255-60. PubMed ID: 18632214
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).
Machtay M; Pajak TF; Suntharalingam M; Shenouda G; Hershock D; Stripp DC; Cmelak AJ; Schulsinger A; Fu KK;
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1008-17. PubMed ID: 17716826
[TBL] [Abstract][Full Text] [Related]
3. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
[TBL] [Abstract][Full Text] [Related]
4. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.
Hoskin PJ; Robinson M; Slevin N; Morgan D; Harrington K; Gaffney C
J Clin Oncol; 2009 Dec; 27(34):5751-6. PubMed ID: 19884550
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment anemia is associated with poorer survival in patients with stage I and II gastric cancer.
Shen JG; Cheong JH; Hyung WJ; Kim J; Choi SH; Noh SH
J Surg Oncol; 2005 Aug; 91(2):126-30. PubMed ID: 16028285
[TBL] [Abstract][Full Text] [Related]
6. Anemia during sequential induction chemotherapy and chemoradiation for head and neck cancer: the impact of blood transfusion on treatment outcome.
Bhide SA; Ahmed M; Rengarajan V; Powell C; Miah A; Newbold K; Nutting CM; Harrington KJ
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):391-8. PubMed ID: 18692326
[TBL] [Abstract][Full Text] [Related]
7. Severity, risk factors, and physician practices in the management of anemia during concurrent chemoradiation for head and neck carcinoma.
Tanvetyanon T; Choudhury AM
Cancer; 2006 Apr; 106(7):1554-9. PubMed ID: 16518817
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for severe Dysphagia after concurrent chemoradiotherapy for head and neck cancers.
Koiwai K; Shikama N; Sasaki S; Shinoda A; Kadoya M
Jpn J Clin Oncol; 2009 Jul; 39(7):413-7. PubMed ID: 19383615
[TBL] [Abstract][Full Text] [Related]
9. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
[TBL] [Abstract][Full Text] [Related]
10. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
11. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
[TBL] [Abstract][Full Text] [Related]
12. A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck.
Fortin A; Caouette R; Wang CS; Vigneault E
Am J Clin Oncol; 2008 Aug; 31(4):379-83. PubMed ID: 18845998
[TBL] [Abstract][Full Text] [Related]
13. Effect of Cisplatin on parotid gland function in concomitant radiochemotherapy.
Hey J; Setz J; Gerlach R; Vordermark D; Gernhardt CR; Kuhnt T
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1475-80. PubMed ID: 19515505
[TBL] [Abstract][Full Text] [Related]
14. Hyperfractionated accelerated radiotherapy versus conventional fractionation both combined with chemotherapy in patients with locally advanced head and neck carcinomas: a retrospective analysis of a monoinstitutional series.
Welz H; Pöttgen C; Abu Jawad J; Wierlemann A; Wittig A; Stüben G; Budach V; Lehnerdt G; Jahnke K; Sack H; Stuschke M
Oncology; 2009; 76(6):405-12. PubMed ID: 19407473
[TBL] [Abstract][Full Text] [Related]
15. Improved survival in patients with Stage III-IV Head and neck cancer treated with radiotherapy as primary local treatment modality.
Rusthoven KE; Raben D; Chen C
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):343-50. PubMed ID: 18374508
[TBL] [Abstract][Full Text] [Related]
16. Influence of smoking and alcohol drinking behaviors on treatment outcomes of patients with squamous cell carcinomas of the head and neck.
Fortin A; Wang CS; Vigneault E
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1062-9. PubMed ID: 19036528
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and efficacy of accelerated weekly concomitant boost postoperative radiation therapy combined with concomitant chemotherapy in patients with locally advanced head and neck cancer.
Pehlivan B; Luthi F; Matzinger O; Betz M; Dragusanu D; Bulling S; Bron L; Pasche P; Seelentag W; Mirimanoff RO; Zouhair A; Ozsahin M
Ann Surg Oncol; 2009 May; 16(5):1337-43. PubMed ID: 19280263
[TBL] [Abstract][Full Text] [Related]
18. Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study.
Dubray B; Mosseri V; Brunin F; Jaulerry C; Poncet P; Rodriguez J; Brugère J; Point D; Giraud P; Cosset JM
Radiology; 1996 Nov; 201(2):553-8. PubMed ID: 8888257
[TBL] [Abstract][Full Text] [Related]
19. [Estimation of treatment results and side-effects in patients with invasive uterine cervix cancer stage IIB-IVA treated with concurrent radiochemotherapy].
Torbé B
Ann Acad Med Stetin; 2008; 54(1):28-40. PubMed ID: 19127807
[TBL] [Abstract][Full Text] [Related]
20. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]